Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

06-Apr-2007

  • Links Between Prostate Cancer Treatment, Periodontal Disease (PRWeb via Yahoo! News)

    Scientists at the University of Pittsburgh School of Dental Medicine have found that men receiving hormone treatments for prostate cancer are much more likely to show gum disease than men who do not receive hormone treatments for prostate cancer.


  • Prostate cancer genetic risk factors found (UPI)

    U.S. researchers have identified seven genetic risk factors -- DNA sequences carried by some but not others -- that predict prostate cancer risk.


  • Cleveland BioLabs Phase II Hormone-Refractory Prostate Cancer Trial Advances to Next Phase (PR Newswire via Yahoo! Finance)

    Cleveland BioLabs, Inc. , announced today that its Phase II efficacy study for Curaxin CBLC102 in advanced, hormone-refractory prostate cancer has progressed to the next phase.


  • Metabolic syndrome tied to cancer in black men (Reuters via Yahoo! News)

    Certain features of the metabolic syndrome are associated with an increased risk of developing prostate cancer in African-American men, according to a report in the journal Cancer.


  • Prostate Cancer Vaccine One Step Closer to Approval (American Cancer Society via Yahoo! News)

    A vaccine to treat prostate cancer came one step closer to approval last week, when an advisory panel to the US Food and Drug Administration said the product was safe and effective.


  • Back to Prostate News Archive